A National Survey of Hereditary Angioedema and Acquired C1 Inhibitor Deficiency in the United Kingdom
Open Access
- 3 May 2023
- journal article
- research article
- Published by Elsevier in The Journal of Allergy and Clinical Immunology: In Practice
- Vol. 11 (8) , 2476-2483
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Epidemiology of Bradykinin-mediated angioedema: a systematic investigation of epidemiological studiesOrphanet Journal of Rare Diseases, 2018
- Mutation of the angiopoietin-1 gene (ANGPT1) associates with a new type of hereditary angioedemaJournal of Allergy and Clinical Immunology, 2018
- Hereditary angioedema with a mutation in the plasminogen geneAllergy, 2017
- Acquired C1 Inhibitor DeficiencyImmunology and Allergy Clinics of North America, 2017
- Prevention of Hereditary Angioedema Attacks with a Subcutaneous C1 InhibitorNew England Journal of Medicine, 2017
- C1 inhibitor deficiency: 2014 United Kingdom consensus documentClinical and Experimental Immunology, 2015
- Paediatric hereditary angioedema: a survey of UK service provision and patient experienceClinical and Experimental Immunology, 2014
- A UK national audit of hereditary and acquired angioedemaClinical and Experimental Immunology, 2013
- A focused parameter update: Hereditary angioedema, acquired C1 inhibitor deficiency, and angiotensin-converting enzyme inhibitor–associated angioedemaJournal of Allergy and Clinical Immunology, 2013
- Hereditary angioedema with normal C1-inhibitor activity in womenThe Lancet, 2000